Business · 03/09/20151 min read

FDA Renewal of Nonprescription Drugs Advisory Committee Charter

The Food and Drug Administration (FDA) is renewing the Nonprescription Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on August 27, 2015. The Commissioner of Food and Drugs has made this decision in the public interest.